https://www.selleckchem.com/pr....oducts/calpeptin.htm
m Pfizer, Inc, to support this work.DISCLOSURES Drs Rind, Campbell, Pearson, Ms Herce-Hagiwara, Ms Fluetsch, and Ms Herron-Smith report grants from Arnold Ventures; Kaiser Foundation Health Plan, Inc; The Patrick and Catherine Donaghue Medical Research Foundation; Blue Cross Blue Shield of Massachusetts; and California Healthcare Foundation during the course of this study.BACKGROUND Metastatic prostate cancer (PC) is associated with declining survival rates and increased health care expenditure. However, there are few studies quantify
Like
Comment
Share
